[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Registration::
Contact us::
Site Facilities::
Ethics::
peer-review::
Indexing::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
Journal DOI

AWT IMAGE

..
Copyright Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 
This Journal is licensed under a Creative Commons Attribution-NonCommercial 4.0
..
:: Volume 15, Issue 2 (3-2013) ::
J Babol Univ Med Sci. 2013; Volume 15 Back to browse issues page
Effects of Single Dose of Erythropoietin on Blood Transfusion Requirement in Patients Undergoing Coronary Artery Bypass Graft Surgery
SH Ziabakhsh-Tabary * , F Mokhtari-Esbuie
Abstract:   (5189 Views)
ABSTRACT
BACKGROUND AND OBJECTIVE: Recently, therapeutic strategies for reducing hemoglobin decrease during and after coronary artery bypass graft surgery was evaluated in a lot of clinic trial studies. In this paper we evaluate effects of single dose of erythropoietin on blood transfusion requirement after coronary artery bypass graft surgery.
METHODS: In this clinic trial study, 60 patients that were candidate for elective coronary artery bypass graft surgery randomly divided into two groups, study and control group. Patients in study group received intravenous infusion of erythropoietin (700 IU/kg), during coronary artery bypass graft surgery. The number of units of pack cell that was infused during surgery and postoperative period was measured. Also hemoglobin concentration was measured and compared before surgery and 5, 15 and 30 days after surgery.
FINDINGS: The mean number of units of pack cell transfused per patients during surgery and postoperative days was significantly decreased in the study group, as compared with control group (2.93± 1.11 vs. 3.7± 1.08, p=0.013). The mean level of hemoglobin concentration on 15 days after surgery (11.03± 1.51 vs. 10.24± 1.14, p=0.018) and also 30 days after surgery (12.6± 1.45 vs. 11.84± 1.21, p=0.03) was significantly higher in study group.
CONCLUSION: The results showed that a single dose of erythropoietin during surgery reduced a perioperative transfusion requirement in the patient undergoing coronary artery bypass graft surgery. Erythropoietin injection also raised a hemoglobin concentration on 15 and 30 days after coronary artery bypass graft surgery in patients in erythropoietin group
Keywords: Erythropoietin, Blood transfusion, Hemoglobin.
Full-Text [PDF 202 kb]   (1527 Downloads)    
Type of Study: Research | Subject: Biochemical
Accepted: 2014/06/10 | Published: 2014/06/10



XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ziabakhsh-Tabary S, Mokhtari-Esbuie F. Effects of Single Dose of Erythropoietin on Blood Transfusion Requirement in Patients Undergoing Coronary Artery Bypass Graft Surgery. J Babol Univ Med Sci 2013; 15 (2) :18-24
URL: http://jbums.org/article-1-4345-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 15, Issue 2 (3-2013) Back to browse issues page
مجله علمی دانشگاه علوم پزشکی بابل Journal of Babol University of Medical Sciences

The Journal of Babol University of Medical Sciences is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Persian site map - English site map - Created in 0.07 seconds with 43 queries by YEKTAWEB 4645